Interim [18F]Fluorodeoxyglucose–Positron Emission Tomography During Neoadjuvant Therapy in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

Epidermal Growth Factor Receptor ◽

Growth Factor Receptor ◽

Emission Tomography ◽

Positron Emission ◽

Epidermal Growth ◽

Fluorodeoxyglucose Positron Emission ◽

Positive Breast Cancer

18F-fluorodeoxyglucose positron emission tomography/computed tomography-based radiomic features for prediction of epidermal growth factor receptor mutation status and prognosis in patients with lung adenocarcinoma

Translational Lung Cancer Research ◽

10.21037/tlcr-19-592 ◽

2020 ◽

Vol 9 (3) ◽

pp. 563-574

Author(s):

Bin Yang ◽

Heng-Shan Ji ◽

Chang-Sheng Zhou ◽

Hao Dong ◽

Lu Ma ◽

...

Keyword(s):

Computed Tomography ◽

Epidermal Growth Factor Receptor ◽

Growth Factor Receptor ◽

Emission Tomography ◽

Mutation Status ◽

Positron Emission ◽

Epidermal Growth ◽

Can 18F-Fluoroestradiol positron emission tomography become a new imaging standard in the estrogen receptor-positive breast cancer patient: A prospective comparative study with 18F-Fluorodeoxyglucose positron emission tomography?

World Journal of Nuclear Medicine ◽

10.4103/1450-1147.203071 ◽

2017 ◽

Vol 16 (2) ◽

pp. 133 ◽

Cited By ~ 6

Author(s):

Manoj Gupta ◽

Anupama Datta ◽

ParthaS Choudhury ◽

Maria Dsouza ◽

Ullas Batra ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Emission Tomography ◽

Positron Emission ◽

Estrogen Receptor Positive ◽

Prospective Comparative Study ◽

Fluorodeoxyglucose Positron Emission ◽

Positive Breast Cancer

[18F]-Fluorodeoxyglucose Positron Emission Tomography Can Contribute to Discriminate Patients with Poor Prognosis in Hormone Receptor-Positive Breast Cancer

PLoS ONE ◽

10.1371/journal.pone.0105905 ◽

2014 ◽

Vol 9 (8) ◽

pp. e105905 ◽

Cited By ~ 9

Author(s):

Sung Gwe Ahn ◽

Minkyung Lee ◽

Tae Joo Jeon ◽

Kyunghwa Han ◽

Hak Min Lee ◽

...

Keyword(s):

Breast Cancer ◽

Poor Prognosis ◽

Emission Tomography ◽

Hormone Receptor Positive ◽

Positron Emission ◽

Fluorodeoxyglucose Positron Emission ◽

Patients With Poor Prognosis ◽

Positive Breast Cancer

68Ga-DTPA Anti-HER2 positron emission tomography/CT successfully predicts the overexpression of human epidermal growth factor receptor in lung metastases from breast cancer

BJR|case reports ◽

10.1259/bjrcr.20160136 ◽

2017 ◽

Vol 3 (3) ◽

pp. 20160136

Author(s):

Quetzali Gabriela Pitalúa-Cortés ◽

Francisco O García-Pérez ◽

Yolanda Villaseñor-Navarro ◽

Fernando Ulises Lara-Medina ◽

Juan Antonio Matus-Santos ◽

...

Keyword(s):

Breast Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Metastases ◽

Growth Factor Receptor ◽

Emission Tomography ◽

Positron Emission ◽

Epidermal Growth

Breast Cancer: Diagnosis of Recurrence Using 18 F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography

Methods of Cancer Diagnosis, Therapy and Prognosis ◽

10.1007/978-1-4020-8369-3_46 ◽

2008 ◽

pp. 653-663

Author(s):

Simona Ben-Haim ◽

Lea Radan

Keyword(s):

Breast Cancer ◽

Computed Tomography ◽

Cancer Diagnosis ◽

Breast Cancer Diagnosis ◽

Emission Tomography ◽

Positron Emission ◽

18F-Fluorodeoxyglucose positron emission tomography optimizes neoadjuvant chemotherapy for primary breast cancer to achieve pathological complete response

International Journal of Clinical Oncology ◽

10.1007/s10147-011-0287-2 ◽

2011 ◽

Vol 17 (3) ◽

pp. 276-282 ◽

Cited By ~ 21

Author(s):

Shigeto Ueda ◽

Toshiaki Saeki ◽

Takashi Shigekawa ◽

Jiro Omata ◽

Tomoyuki Moriya ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Primary Breast Cancer ◽

Pathological Complete Response ◽

Complete Response ◽

Emission Tomography ◽

Positron Emission ◽

Fluorodeoxyglucose positron emission tomography/computed tomography findings after percutaneous cryoablation of early breast cancer

Cancer Imaging ◽

10.1186/s40644-020-00325-y ◽

2020 ◽

Vol 20 (1) ◽

Author(s):

Takuya Adachi ◽

Youichi Machida ◽

Eisuke Fukuma ◽

Ukihide Tateishi

Keyword(s):

Breast Cancer ◽

Computed Tomography ◽

Early Breast Cancer ◽

Emission Tomography ◽

Percutaneous Cryoablation ◽

Positron Emission ◽

Staging/restaging performance of F18-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in breast cancer: A review and meta-analysis

European Journal of Radiology ◽

10.1016/j.ejrad.2018.09.003 ◽

2018 ◽

Vol 107 ◽

pp. 158-165 ◽

Cited By ~ 2

Author(s):

Chun-Yi Lin ◽

Cheng-Li Lin ◽

Chia-Hung Kao

Keyword(s):

Breast Cancer ◽

Magnetic Resonance Imaging ◽

Magnetic Resonance ◽

Meta Analysis ◽

Emission Tomography ◽

Resonance Imaging ◽

Positron Emission ◽

Maximum standardized uptake value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography could replace pathological diagnosis in luminal breast cancer

Annals of Breast Surgery ◽

10.21037/abs.2019.02.01 ◽

2019 ◽

Vol 3 ◽

pp. 5-5

Author(s):

Shinya Yamamoto ◽

Shigeru Yamagishi ◽

Toshiro Kohno ◽

Ryosuke Tajiri ◽

Toshikazu Gondo ◽

...

Keyword(s):

Breast Cancer ◽

Computed Tomography ◽

Standardized Uptake Value ◽

Emission Tomography ◽

Luminal Breast Cancer ◽

Maximum Standardized Uptake Value ◽

Positron Emission ◽

Standardized uptake value of 18F-fluorodeoxyglucose positron emission tomography for prediction of tumor recurrence in breast cancer beyond tumor burden

Breast Cancer Research ◽

10.1186/s13058-014-0502-y ◽

2014 ◽

Vol 16 (6) ◽

Cited By ~ 21

Author(s):

Sung Gwe Ahn ◽

Jong Tae Park ◽

Hak Min Lee ◽

Hak Woo Lee ◽

Tae Joo Jeon ◽

...

Keyword(s):

Breast Cancer ◽

Tumor Recurrence ◽

Standardized Uptake Value ◽

Tumor Burden ◽

Emission Tomography ◽

18F Fluorodeoxyglucose ◽

Positron Emission ◽